Cargando…

Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+

BACKGROUND: Influenza and pneumococcal vaccination can prevent disease and potentially life-threatening complications like sepsis. Elderly people have an increased risk of severe disease and therefore constitute a major target group for vaccination. To increase vaccination coverage, targeted interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Betsch, Cornelia, Rossmann, Constanze, Pletz, Mathias W., Vollmar, Horst C., Freytag, Antje, Wichmann, Ole, Hanke, Regina, Hanke, Wolfgang, Heinemeier, Dorothee, Schmid, Philipp, Eitze, Sarah, Weber, Winja, Reinhardt, Anne, Küpke, Nora K., Forstner, Christina, Fleischmann-Struzek, Carolin, Mikolajetz, Anna, Römhild, Josephine, Neufeind, Julia, Rieck, Thorsten, Suchecka, Kasia, Reinhart, Konrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048840/
https://www.ncbi.nlm.nih.gov/pubmed/30012141
http://dx.doi.org/10.1186/s12889-018-5787-9
_version_ 1783340172668043264
author Betsch, Cornelia
Rossmann, Constanze
Pletz, Mathias W.
Vollmar, Horst C.
Freytag, Antje
Wichmann, Ole
Hanke, Regina
Hanke, Wolfgang
Heinemeier, Dorothee
Schmid, Philipp
Eitze, Sarah
Weber, Winja
Reinhardt, Anne
Küpke, Nora K.
Forstner, Christina
Fleischmann-Struzek, Carolin
Mikolajetz, Anna
Römhild, Josephine
Neufeind, Julia
Rieck, Thorsten
Suchecka, Kasia
Reinhart, Konrad
author_facet Betsch, Cornelia
Rossmann, Constanze
Pletz, Mathias W.
Vollmar, Horst C.
Freytag, Antje
Wichmann, Ole
Hanke, Regina
Hanke, Wolfgang
Heinemeier, Dorothee
Schmid, Philipp
Eitze, Sarah
Weber, Winja
Reinhardt, Anne
Küpke, Nora K.
Forstner, Christina
Fleischmann-Struzek, Carolin
Mikolajetz, Anna
Römhild, Josephine
Neufeind, Julia
Rieck, Thorsten
Suchecka, Kasia
Reinhart, Konrad
author_sort Betsch, Cornelia
collection PubMed
description BACKGROUND: Influenza and pneumococcal vaccination can prevent disease and potentially life-threatening complications like sepsis. Elderly people have an increased risk of severe disease and therefore constitute a major target group for vaccination. To increase vaccination coverage, targeted interventions are needed that take theory-based specific determinants of vaccination behaviour into account. Moreover, message and campaign design should consider specific age-related characteristics (e.g., information processing, media use). The aim of this study is (i) to identify the specific informational and interventional needs of this risk group, (ii) to design and implement a targeted intervention aiming to decrease vaccine hesitancy, increase vaccine uptake and decrease the health and economic burden due to the respective diseases, and (iii) to measure the effect of this evidence-informed intervention on various levels. METHODS: Prospective, multi-methods intervention study targeting individuals aged ≥60 years in a model region in Germany (federal state of Thuringia, 500,000 inhabitants ≥60 years old). The development of the intervention follows theory-based and evidence-informed principles: Data from a cross-sectional representative study provide insights into specific determinants of the target group’s vaccination behaviour. Additionally, media use is analysed to identify adequate communication channels for specific subgroups. In pilot studies, the intervention materials are adapted to the specific cognitive requirements of the target group. For development and implementation of the intervention, an interdisciplinary and trans-sectoral approach is used, including psychology, communication science, design, medical science, epidemiology and various public health players. The intervention will be implemented in autumn and winter 2017/18 and 2018/19 and adjusted in between. Evaluation of the intervention includes: awareness, use and recall of intervention materials, effects on changes in determinants of vaccination behaviour, self-reported vaccine uptake, and vaccination coverage in the intervention area (primary outcomes), as well as disease incidences (secondary outcomes) and the economic burden of influenza, pneumonia, invasive pneumococcal disease and sepsis for the healthcare system (tertiary outcomes). DISCUSSION: The data will add to the body of evidence on the effectiveness of evidence-informed vaccination campaign development as well as on the clinical and economic effects of pneumococcal and influenza vaccination. The effect of the intervention will teach valuable lessons about the principles of campaign development and evaluation, and can motivate a subsequent nationwide intervention. TRIAL REGISTRATION: DRKS00012653. Registered 24.11.2017. Retrospectively registered.
format Online
Article
Text
id pubmed-6048840
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60488402018-07-19 Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+ Betsch, Cornelia Rossmann, Constanze Pletz, Mathias W. Vollmar, Horst C. Freytag, Antje Wichmann, Ole Hanke, Regina Hanke, Wolfgang Heinemeier, Dorothee Schmid, Philipp Eitze, Sarah Weber, Winja Reinhardt, Anne Küpke, Nora K. Forstner, Christina Fleischmann-Struzek, Carolin Mikolajetz, Anna Römhild, Josephine Neufeind, Julia Rieck, Thorsten Suchecka, Kasia Reinhart, Konrad BMC Public Health Study Protocol BACKGROUND: Influenza and pneumococcal vaccination can prevent disease and potentially life-threatening complications like sepsis. Elderly people have an increased risk of severe disease and therefore constitute a major target group for vaccination. To increase vaccination coverage, targeted interventions are needed that take theory-based specific determinants of vaccination behaviour into account. Moreover, message and campaign design should consider specific age-related characteristics (e.g., information processing, media use). The aim of this study is (i) to identify the specific informational and interventional needs of this risk group, (ii) to design and implement a targeted intervention aiming to decrease vaccine hesitancy, increase vaccine uptake and decrease the health and economic burden due to the respective diseases, and (iii) to measure the effect of this evidence-informed intervention on various levels. METHODS: Prospective, multi-methods intervention study targeting individuals aged ≥60 years in a model region in Germany (federal state of Thuringia, 500,000 inhabitants ≥60 years old). The development of the intervention follows theory-based and evidence-informed principles: Data from a cross-sectional representative study provide insights into specific determinants of the target group’s vaccination behaviour. Additionally, media use is analysed to identify adequate communication channels for specific subgroups. In pilot studies, the intervention materials are adapted to the specific cognitive requirements of the target group. For development and implementation of the intervention, an interdisciplinary and trans-sectoral approach is used, including psychology, communication science, design, medical science, epidemiology and various public health players. The intervention will be implemented in autumn and winter 2017/18 and 2018/19 and adjusted in between. Evaluation of the intervention includes: awareness, use and recall of intervention materials, effects on changes in determinants of vaccination behaviour, self-reported vaccine uptake, and vaccination coverage in the intervention area (primary outcomes), as well as disease incidences (secondary outcomes) and the economic burden of influenza, pneumonia, invasive pneumococcal disease and sepsis for the healthcare system (tertiary outcomes). DISCUSSION: The data will add to the body of evidence on the effectiveness of evidence-informed vaccination campaign development as well as on the clinical and economic effects of pneumococcal and influenza vaccination. The effect of the intervention will teach valuable lessons about the principles of campaign development and evaluation, and can motivate a subsequent nationwide intervention. TRIAL REGISTRATION: DRKS00012653. Registered 24.11.2017. Retrospectively registered. BioMed Central 2018-07-16 /pmc/articles/PMC6048840/ /pubmed/30012141 http://dx.doi.org/10.1186/s12889-018-5787-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Betsch, Cornelia
Rossmann, Constanze
Pletz, Mathias W.
Vollmar, Horst C.
Freytag, Antje
Wichmann, Ole
Hanke, Regina
Hanke, Wolfgang
Heinemeier, Dorothee
Schmid, Philipp
Eitze, Sarah
Weber, Winja
Reinhardt, Anne
Küpke, Nora K.
Forstner, Christina
Fleischmann-Struzek, Carolin
Mikolajetz, Anna
Römhild, Josephine
Neufeind, Julia
Rieck, Thorsten
Suchecka, Kasia
Reinhart, Konrad
Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
title Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
title_full Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
title_fullStr Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
title_full_unstemmed Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
title_short Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
title_sort increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study vaccination60+
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048840/
https://www.ncbi.nlm.nih.gov/pubmed/30012141
http://dx.doi.org/10.1186/s12889-018-5787-9
work_keys_str_mv AT betschcornelia increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT rossmannconstanze increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT pletzmathiasw increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT vollmarhorstc increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT freytagantje increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT wichmannole increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT hankeregina increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT hankewolfgang increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT heinemeierdorothee increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT schmidphilipp increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT eitzesarah increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT weberwinja increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT reinhardtanne increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT kupkenorak increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT forstnerchristina increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT fleischmannstruzekcarolin increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT mikolajetzanna increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT romhildjosephine increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT neufeindjulia increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT rieckthorsten increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT sucheckakasia increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60
AT reinhartkonrad increasinginfluenzaandpneumococcalvaccineuptakeintheelderlystudyprotocolforthemultimethodsprospectiveinterventionstudyvaccination60